Steven Feldman to Economics, Pharmaceutical
This is a "connection" page, showing publications Steven Feldman has written about Economics, Pharmaceutical.
Connection Strength
0.647
-
Neidecker MV, Davis-Ajami ML, Balkrishnan R, Feldman SR. Pharmacoeconomic considerations in treating actinic keratosis. Pharmacoeconomics. 2009; 27(6):451-64.
Score: 0.331
-
Vale SM, Hill D, Feldman SR. Pharmacoeconomic Considerations in Treating Actinic Keratosis: An Update. Pharmacoeconomics. 2017 02; 35(2):177-190.
Score: 0.145
-
Staidle JP, Dabade TS, Feldman SR. A pharmacoeconomic analysis of severe psoriasis therapy: a review of treatment choices and cost efficiency. Expert Opin Pharmacother. 2011 Sep; 12(13):2041-54.
Score: 0.098
-
Steele T, Pawaskar M, Balkrishnan R, Fleischer A, Feldman SR. Does cost-effectiveness play a role in clinical trials? Dermatol Ther. 2007 Mar-Apr; 20(2):110-9.
Score: 0.073